loading
Bausch Health Companies Inc stock is traded at $4.92, with a volume of 1.30M. It is up +2.47% in the last 24 hours and down -8.22% over the past month. Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
See More
Previous Close:
$4.81
Open:
$4.87
24h Volume:
1.30M
Relative Volume:
0.63
Market Cap:
$1.84B
Revenue:
$10.53B
Net Income/Loss:
$-1.23B
P/E Ratio:
-1.5157
EPS:
-3.246
Net Cash Flow:
$949.99M
1W Performance:
-0.03%
1M Performance:
-8.22%
6M Performance:
-37.61%
1Y Performance:
-28.26%
1-Day Range:
Value
$4.85
$5.005
1-Week Range:
Value
$4.74
$5.005
52-Week Range:
Value
$4.565
$8.685

Bausch Health Companies Inc Stock (BHC) Company Profile

Name
Name
Bausch Health Companies Inc
Name
Phone
514-744-6792
Name
Address
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Name
Employee
20,300
Name
Twitter
Name
Next Earnings Date
2026-07-29
Name
Latest SEC Filings
Name
BHC's Discussions on Twitter

Compare BHC vs TAK, HLN, TEVA, ZTS, UTHR

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
BHC icon
BHC
Bausch Health Companies Inc
4.925 1.83B 10.53B -1.23B 949.99M -3.246
TAK icon
TAK
Takeda Pharmaceutical Co Adr
16.97 52.99B 29.91B 1.30B 3.49B 0.4056
HLN icon
HLN
Haleon Plc Adr
9.805 43.25B 14.54B 2.22B 2.58B 0.4871
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
34.74 40.34B 17.53B 1.58B 444.18M 1.3457
ZTS icon
ZTS
Zoetis Inc
76.32 31.36B 9.51B 2.64B 2.14B 6.0361
UTHR icon
UTHR
United Therapeutics Corp
560.21 23.60B 3.17B 1.29B 1.01B 27.09

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-09-25 Initiated Barclays Equal Weight
Aug-02-24 Downgrade Piper Sandler Neutral → Underweight
Jul-10-24 Initiated Raymond James Mkt Perform
Sep-20-23 Upgrade Jefferies Hold → Buy
Jun-16-23 Downgrade TD Cowen Outperform → Market Perform
Jul-29-22 Downgrade RBC Capital Mkts Outperform → Sector Perform
Jul-29-22 Downgrade Truist Buy → Hold
Jul-28-22 Downgrade JP Morgan Overweight → Neutral
Jun-13-22 Resumed JP Morgan Overweight
Mar-24-21 Downgrade BofA Securities Neutral → Underperform
Feb-17-21 Upgrade RBC Capital Mkts Sector Perform → Outperform
Jan-22-21 Downgrade Piper Sandler Overweight → Neutral
Sep-17-20 Upgrade BofA Securities Underperform → Neutral
Aug-24-20 Reiterated H.C. Wainwright Buy
Jun-17-20 Reiterated H.C. Wainwright Buy
Apr-24-20 Initiated Citigroup Buy
Apr-02-20 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-29-20 Downgrade Wolfe Research Outperform → Peer Perform
Jan-22-20 Upgrade Wells Fargo Underweight → Equal Weight
Dec-12-19 Upgrade JP Morgan Neutral → Overweight
Dec-02-19 Initiated Goldman Neutral
Oct-25-19 Initiated Cowen Outperform
Sep-12-19 Initiated Guggenheim Buy
Aug-15-19 Upgrade TD Securities Hold → Buy
Jul-19-19 Initiated Wolfe Research Outperform
Jun-11-19 Resumed Barclays Overweight
May-13-19 Upgrade JP Morgan Underweight → Neutral
Mar-20-19 Initiated SunTrust Buy
Jan-02-19 Upgrade Piper Jaffray Neutral → Overweight
Nov-05-18 Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-13-18 Upgrade Piper Jaffray Underweight → Neutral
View All

Bausch Health Companies Inc Stock (BHC) Latest News

pulisher
07:05 AM

Bausch Health plans July 29 call for Q2 results and business update - Stock Titan

07:05 AM
pulisher
07:00 AM

Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026 - TradingView

07:00 AM
pulisher
Jul 06, 2026

Bausch Health Continues Specialty Pharma Strategy In 6 July 2026 - Kalkine Media

Jul 06, 2026
pulisher
Jul 06, 2026

Why Did Bausch Health (TSX:BHC) Announce a Board Change? - Kalkine Media

Jul 06, 2026
pulisher
Jul 06, 2026

Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia - Yahoo! Finance Canada

Jul 06, 2026
pulisher
Jul 03, 2026

Bausch Health Companies (BHC) Posts Modest Gain, Tests Resistance ZoneETF AUM Growth - dars.gov.et

Jul 03, 2026
pulisher
Jul 02, 2026

Bausch Health (BHC) director granted RSUs in lieu of cash fees - Stock Titan

Jul 02, 2026
pulisher
Jul 02, 2026

Bausch Health (NYSE: BHC) director John Paulson granted 12,677 RSUs as board pay - Stock Titan

Jul 02, 2026
pulisher
Jul 02, 2026

Bausch Health (NYSE: BHC) director granted 6,845 RSUs as board compensation - Stock Titan

Jul 02, 2026
pulisher
Jul 02, 2026

Bausch Health (TSX:BHC) Board Change Follows Director Resignation - Kalkine Media

Jul 02, 2026
pulisher
Jul 02, 2026

Best TSX Healthcare Stocks to Watch for July 2026 - Kalkine Media

Jul 02, 2026
pulisher
Jul 01, 2026

Michael Goettler Resigns from Bausch Health's Board of Directors - The Globe and Mail

Jul 01, 2026
pulisher
Jul 01, 2026

Director Michael Goettler exits Bausch Health (NYSE: BHC) board - Stock Titan

Jul 01, 2026
pulisher
Jul 01, 2026

Bausch + Lomb survey finds dry eye affects emotional health By Investing.com - Investing.com South Africa

Jul 01, 2026
pulisher
Jun 29, 2026

Why Is Bausch Health (TSX:BHC) Expanding Beyond the S&P/TSX? - Kalkine Media

Jun 29, 2026
pulisher
Jun 27, 2026

BVF Forecast — Price Target — Prediction for 2027 - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Bausch Health (BHC) Drops Nearly 10%: Support Levels in Focus After Sharp DeclineMean Reversion Trade - dars.gov.et

Jun 27, 2026
pulisher
Jun 27, 2026

Bausch Health Companies Inc. Actuals & Estimates (TSX:BHC) - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Bausch Health Companies Inc. Actuals & Estimates (TRADEGATE:BVF) - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Bausch Health Companies Inc. Actuals & Estimates (MUN:BVF) - TradingView

Jun 27, 2026
pulisher
Jun 26, 2026

Price to earnings forward of Bausch Health Companies Inc. – FWB:BVF - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Bausch Health Companies Inc. Actuals & Estimates (NYSE:BHC) - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

Bausch Health Companies Inc. Actuals & Estimates (FWB:BVF) - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Bausch Health Companies Inc. Actuals & Estimates (BOATS:BHC) - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Bausch Health Companies Inc. Actuals & Estimates (LSX:A2JQ1X) - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Bausch Health Companies Inc. Actuals & Estimates (BIVA:BHC/N) - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

BHC Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Bausch Health Companies adjusts debt profile, shares react to refinancing step - AD HOC NEWS

Jun 25, 2026
pulisher
Jun 25, 2026

Price to earnings forward of Bausch Health Companies Inc. – BOATS:BHC - TradingView

Jun 25, 2026
pulisher
Jun 23, 2026

Bausch Health Companies Inc (BHC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 23, 2026
pulisher
Jun 22, 2026

Biotrue Hydration Boost Rehydrating Contact Lens Drops from Bausch Health Companiesquiet comfort - Ad-hoc-news.de

Jun 22, 2026
pulisher
Jun 22, 2026

Can Bausch Health (TSX:BHC) Drive TSX Healthcare Stocks Higher? - Kalkine Media

Jun 22, 2026
pulisher
Jun 19, 2026

Why Is Bausch Health (TSX:BHC) Expanding Its S&P/TSX Composite Footprint? - Kalkine Media

Jun 19, 2026
pulisher
Jun 18, 2026

Bausch Health Cos (BHC) Institutional Ownership 2026 $BHC - MarketBeat

Jun 18, 2026
pulisher
Jun 17, 2026

Bausch Health Companies Inc (BHC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Bausch Health Companies Inc (BHC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Bausch Health Companies Inc - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Bausch Health’s Debt Strategy Shapes Its Market Narrative - Kalkine Media

Jun 17, 2026
pulisher
Jun 17, 2026

Bausch Health Companies Inc (BHC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Bausch Health Companies Inc (BHC) Institutional Confidence - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Bausch Health Companies Inc (BHC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Bausch Health Companies Inc (BHC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Bausch Health Companies Inc (BHC) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 16, 2026

Bausch Health stock hits 52-week low at 4.91 USD By Investing.com - Investing.com South Africa

Jun 16, 2026
pulisher
Jun 16, 2026

Bausch Health stock hits 52-week low at 4.91 USD - Investing.com

Jun 16, 2026
pulisher
Jun 15, 2026

Actinic Keratosis Market to Witness Transformational Growth Opportunities by 2036 – DelveInsight | Almirall, Biofrontera Pharma, Vidac Pharma, Rubedo Life Sciences, Bausch Health, Sandoz Pharma - Barchart.com

Jun 15, 2026
pulisher
Jun 11, 2026

TSX Healthcare Stocks: Which Names Are Drawing Market Attention? - Kalkine Media

Jun 11, 2026
pulisher
Jun 09, 2026

BHC Q1 2026 Earnings: EPS Surges 12.33% Above Estimates, Shares Edge HigherEarnings Surprise Score - newsline.com

Jun 09, 2026
pulisher
Jun 09, 2026

Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI® (Risperidone for extended-release injectable suspension) for the treatment of schizophrenia - Cantech Letter

Jun 09, 2026
pulisher
Jun 08, 2026

Why Bausch Health Companies Inc stock is sliding today - Wealth Awesome

Jun 08, 2026
pulisher
Jun 04, 2026

Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $7 - Moomoo

Jun 04, 2026

Bausch Health Companies Inc Stock (BHC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$55.14
price down icon 0.05%
RDY RDY
$14.68
price up icon 2.19%
$24.74
price down icon 1.55%
$177.41
price up icon 1.96%
$17.00
price up icon 1.16%
$560.63
price up icon 2.44%
Cap:     |  Volume (24h):